Results 91 to 100 of about 13,238 (216)

Short‐Term Adverse Events Following Recombinant Zoster Vaccination in Older Adults in Australia: A Survey Study Comparing Dose 1 and Dose 2 and Influence of Dose Interval

open access: yesMedical Journal of Australia, Volume 224, Issue 11, November 2026.
ABSTRACT Self‐reported adverse events following first and second recombinant zoster vaccination (RZV) doses in older adults (n = 41,069) collected through AusVaxSafety were analysed. Adverse event rates were higher following Dose 2 (54%; 95% CI, 53%–54%) than after Dose 1 (45%; 95% CI, 45%–46%), particularly with 3–6‐ and 7–9‐month dose intervals ...
Lucy Dawes   +3 more
wiley   +1 more source

Safety and reactogenicity of COVID-19 vaccines

open access: yes, 2021
The Australian Government has detailed a national rollout strategy for the delivery of COVID-19 vaccines. In the Phase 1a, vaccines will be available to quarantine and border workers, priority sub-groups of frontline health workers, and aged care and ...
Marnie, C., Peters, M.
core  

Engineering mRNA‐LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases

open access: yesExploration, Volume 6, Issue 5, October 2026.
This review highlights recent advances in engineering messenger RNA (mRNA)‐lipid nanoparticles (LNPs) to cross the ageing blood–brain barrier and target neurodegenerative diseases. It outlines design principles, delivery routes, and translational challenges, charting a roadmap towards clinical application of mRNA‐LNP therapeutics for neurodegenerative ...
Abdel Ali Belaidi   +5 more
wiley   +1 more source

Table_2_Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.pdf

open access: yes, 2023
IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.
Thiago Dominguez Crespo Hirata (14435474)   +17 more
core   +1 more source

Post‐Vaccination Chemosensory Dysfunction: Changes Following SARS‐CoV‐2 Vaccination in a Global Study

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 5, October 2026.
ABSTRACT Objective To assess post‐vaccination changes in chemosensory function among individuals with and without COVID‐19‐related chemosensory impairment. Methods In this global, multilingual online survey, participants reported vaccination status, vaccine side effects, and changes in smell and taste before and after each vaccine dose.
Sachiko Koyama   +17 more
wiley   +1 more source

Image_1_Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.pdf

open access: yes, 2023
IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.
Thiago Dominguez Crespo Hirata (14435474)   +17 more
core   +1 more source

Chemical and Biological Determinants of PEG‐Lipid Shedding From Therapeutic Nanoparticles

open access: yesSmall, Volume 22, Issue 58, 16 October 2026.
PEG‐lipids play a central role in governing lipid nanoparticle stability, targeting, and function. However, PEG‐lipids can “shed” from the nanoparticle surface in biological environments, with the extent and kinetics of shedding influenced by chemical and biological factors.
Ethan P. Cisneros   +2 more
wiley   +1 more source

Table_1_Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.pdf

open access: yes, 2023
IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.
Thiago Dominguez Crespo Hirata (14435474)   +17 more
core   +1 more source

Association between Reactogenicity and Immunogenicity in a Vaccinated Cohort with Two mRNA SARS-CoV-2 Vaccines at a High-Complexity Reference Hospital: A Post Hoc Analysis on Immunology Aspects of a Prospective Cohort Study

open access: yesVaccines
Enhancing our comprehension of mRNA vaccines may facilitate the future design of novel vaccines aimed at augmenting immune protection while minimising reactogenic responses. Before this design is carried out, it is important to determine whether adaptive
Joaquín Sáez-Peñataro   +6 more
doaj   +1 more source

Identifying Potential Candidate Hub Genes and Functionally Enriched Pathways in the Immune Responses to Quadrivalent Inactivated Influenza Vaccines in the Elderly Through Co-Expression Network Analysis

open access: yesFrontiers in Immunology, 2020
Insights into the potential candidate hub genes may facilitate the generation of safe and effective immunity against seasonal influenza as well as the development of personalized influenza vaccines for the elderly at high risk of influenza virus ...
Jing Yang   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy